![Foto de Luis de la](/img/nophoto.png)
Luis de la
Cruz-Merino
Luis de la Cruz-Merino-rekin lankidetzan egindako argitalpenak (1)
2021
-
Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 6, pp. 586-598